(Report ID: 27038) Drug interactions analysis of: Coumadin, Flonase, Flovent, Combivent, Proventil, Flagyl, Vibramycin, PrednisoneMany drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 21, 2008, eHealthMe analyzes 10,180,646 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 21, 2008: 4 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 27038 | Jun, 29, 2005 | 67 | Female |
List of drugs the patient takes:
| Drug |
Coumadin |
Flonase |
Flovent |
Combivent |
Proventil |
Flagyl |
Vibramycin |
Prednisone |
List of drug interactions, adverse side effects / events the patient has:
| Name |
Gastrointestinal Haemorrhage |
Results from eHealthMe: 4 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Gastrointestinal Haemorrhage | 1 (25.00%) |
2) Top drug interactions, adverse side effects reported for the past 12 months:Death: 0 Cancer: 0
| Name | Count (% of total reports) |
1 | Orthostatic Hypotension | 2 (100.00%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Methylprednisolone | 6 |
2 | Morphine | 4 |
3 | Zolpidem Tartrate | 4 |
4 | Guaifenesin | 4 |
5 | Levofloxacin | 4 |
6 | Xanax | 2 |
7 | Flunisolide | 2 |
8 | Lipitor | 2 |
9 | Spironolactone | 2 |
10 | Gabapentin | 2 |
4) Top drug interactions, adverse side effects reported of all time:Death: 0 Cancer: 0
| Name | Count (% of total reports) |
1 | Orthostatic Hypotension | 2 (50.00%) |
2 | Implant Site Reaction Nos | 1 (25.00%) |
3 | Leukopenia Nos | 1 (25.00%) |
4 | Nausea | 1 (25.00%) |
5 | Hiatus Hernia | 1 (25.00%) |
6 | Haemolytic Anaemia Nos | 1 (25.00%) |
7 | Blood Disorder Nos | 1 (25.00%) |
8 | Drug Interaction Nos | 1 (25.00%) |
9 | Gastrointestinal Haemorrhage | 1 (25.00%) |
5) Top co-used drugs drugs reported of all time:
| Name | Count |
1 | Methylprednisolone | 6 |
2 | Morphine | 4 |
3 | Zolpidem Tartrate | 4 |
4 | Guaifenesin | 4 |
5 | Levofloxacin | 4 |
6 | Atacand | 2 |
7 | Flunisolide | 2 |
8 | Lipitor | 2 |
9 | Spironolactone | 2 |
10 | Gabapentin | 2 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
Depakote (Abbott) - EQ 500MG VALPROIC... for Epilepsy (Nov, 21, 2008)
|
Cymbalta (Lilly) - EQ 20MG BASE for Depression (Nov, 21, 2008)
|
Vicodin Es (Abbott) - 750MG;7.5MG for Toothaches (Nov, 21, 2008)
|
Vicodin Es (Abbott) - 750MG;7.5MG for Toothaches (Nov, 21, 2008)
|
Lyrica (Pfizer) - 100MG for Back Pain - Low (Nov, 21, 2008)
|
Sodium Bicarbonate (Hospira) - 0.9MEQ... for Heartburn (Nov, 21, 2008)
|
Side effects comparison of Lipitor (Pfizer) - EQ 20MG BASE (Nov, 21, 2008)
|
Lipitor (Pfizer) - EQ 20MG BASE for Cholesterol (Nov, 21, 2008)
|
Lipitor (Pfizer) - EQ 20MG BASE for Cholesterol (Nov, 21, 2008)
|
Digoxin (Roxane) - 0.05MG/ML for Heart Condition (Nov, 21, 2008)
|
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|